Edward K. Han

3.3k total citations
32 papers, 1.9k citations indexed

About

Edward K. Han is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Edward K. Han has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Edward K. Han's work include Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (4 papers) and Cancer therapeutics and mechanisms (4 papers). Edward K. Han is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (4 papers) and Cancer therapeutics and mechanisms (4 papers). Edward K. Han collaborates with scholars based in United States and United Kingdom. Edward K. Han's co-authors include I. Bernard Weinstein, Alessandro Sgambato, Martin Begemann, I B Weinstein, Angela Cacace, Nadir Arber, Thomas McGonigal, Vincent L. Giranda, Sajid Khan Tahir and Marius Ueffing and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Oncogene.

In The Last Decade

Edward K. Han

32 papers receiving 1.8k citations

Peers

Countries citing papers authored by Edward K. Han

Since Specialization

Citations

This map shows the geographic impact of Edward K. Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward K. Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward K. Han more than expected).

Fields of papers citing papers by Edward K. Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward K. Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward K. Han. The network helps show where Edward K. Han may publish in the future.

Co-authorship network of co-authors of Edward K. Han

This figure shows the co-authorship network connecting the top 25 collaborators of Edward K. Han. A scholar is included among the top collaborators of Edward K. Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward K. Han. Edward K. Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET –Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence 2016 ·Clinical Cancer Research ·Jieyi Wang, Mark G. Anderson, Anatol Oleksijew, Kedar S. Vaidya, Erwin R. Boghaert, Lora A. Tucker, Qian Zhang, Edward K. Han, Joann P. Palma, Louie Naumovski, Edward B. Reilly	104
2	Acute Pancreatitis Associated With Antipsychotic Medication 2016 ·Journal of Clinical Psychopharmacology ·(unknown), (unknown), Edward K. Han, Michael J. Malloy	20
3	Aminopyrimidinone Cdc7 Kinase Inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Keith W. Woods, Chunqiu Lai, Julie M. Miyashiro, Yunsong Tong, Alan S. Florjancic, Edward K. Han, Niru B. Soni, Yan Shi, Loren Lasko, Joel Johansson, Eric F. Johnson, Alexander R. Shoemaker, Thomas D. Penning	18
4	Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways 2009 ·Molecular Cancer Research ·Xuesong Liu, Edward K. Han, Mark G. Anderson, Yan Shi, Dimitri Semizarov, Gang Wang, Thomas McGonigal, Lisa Roberts, Loren Lasko, Joann P. Palma, Gui‐Dong Zhu, Thomas D. Penning, Saul H. Rosenberg, Vincent L. Giranda, Yan Luo, Joel Johansson, Eric F. Johnson, Alexander R. Shoemaker	77
5	Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells. 2008 ·PubMed ·Edward K. Han, Thomas McGonigal, Christopher Butler, Vincent L. Giranda, Yan Luo	39
6	Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery 2007 ·Anti-Cancer Agents in Medicinal Chemistry ·Edward K. Han, Thomas McGonigal	26
7	Optimal Classes of Chemotherapeutic Agents Sensitized by Specific Small-Molecule Inhibitors of Akt In Vitro and In Vivo 2005 ·Neoplasia ·Yan Shi, Xuesong Liu, Edward K. Han, Ran Guan, Alexander R. Shoemaker, Anatol Oleksijew, Keith W. Woods, John P. Fisher, Vered Klinghofer, Loren Lasko, Thomas McGonigal, Qun Li, Saul H. Rosenberg, Vincent L. Giranda, Yan Luo	35
8	Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents. 2001 ·PubMed ·Yan Luo, (unknown), Mary K. Joseph, (unknown), Christopher Butler, Stephen K. Tahir, Edward K. Han, Shi‐Chung Ng, Jean M. Severin, Earl J. Gubbins, Regina M. Reilly, (unknown), Robert L. Simmer, (unknown), Vincent L. Giranda	28
9	Downregulation of Akt1 Inhibits Anchorage-Independent Cell Growth and Induces Apoptosis in Cancer Cells 2001 ·Neoplasia ·Xuesong Liu, Yan Shi, Edward K. Han, Zehan Chen, Saul H. Rosenberg, Vincent L. Giranda, Yan Luo, Shi‐Chung Ng	40
10	Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism 2001 ·Neoplasia ·Yan Luo, (unknown), Paul E. Kroeger, Leigh Frost, Zehan Chen, Edward K. Han, Shi‐Chung Ng, Robert L. Simmer, Vincent L. Giranda	39
11	Modulation of drug resistance by α-tubulin in paclitaxel-resistant human lung cancer cell lines 2000 ·European Journal of Cancer ·Edward K. Han, Laura Gehrke, Sajid Khan Tahir, R.B. Credo, Sajeev Cherian, Hing L. Sham, S.H. Rosenberg, Shi Chung Ng	43
12	Modulation of paclitaxel resistance by annexin IV in human cancer cell lines 2000 ·British Journal of Cancer ·Edward K. Han, Sajid Khan Tahir, Sajeev Cherian, Nathan Collins, (unknown)	88
13	Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis 1999 ·APOPTOSIS ·Edward K. Han, Shi Chung Ng, Nadir Arber, Martin Begemann, I. Bernard Weinstein	66
14	The α isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells 1999 ·Oncogene ·Eric D. Slosberg, Michael G. Klein, Yao Yao, Edward K. Han, Ira Schieren, I B Weinstein	29
15	Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines 1999 ·Biochemical Pharmacology ·Jin T. E. Lim, Gary A. Piazza, Edward K. Han, Thomas Delohery, Li Han, Tyler S. Finn, Ralph Buttyan, Hirofumi Yamamoto, Gerhard Sperl, Klaus Brendel, Paul H. Gross, Rifat Pamukcu, I. Bernard Weinstein	180
16	Overexpression of PKCɛ in R6 fibroblasts causes increased production of active TGFβ 1998 ·Journal of Cellular Physiology ·Angela Cacace, Marius Ueffing, Edward K. Han, Dieter Marmé, I. Bernard Weinstein	25
17	Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines 1998 ·Breast Cancer Research and Treatment ·Edward K. Han, Nadir Arber, Hirofumi Yamamoto, Jin T. E. Lim, (unknown), Rifat Pamukcu, Gary A. Piazza, (unknown), I. Bernard Weinstein	65
18	A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes 1997 ·Gastroenterology ·Nadir Arber, Edward K. Han, Alessandro Sgambato, Gary A. Piazza, Thomas Delohery, Martin Begemann, Christopher M. Weghorst, (unknown), Rifat Pamukcu, (unknown), John C. Reed, I. Bernard Weinstein, Peter R. Holt	67
19	Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. 1997 ·PubMed ·I. Bernard Weinstein, Martin Begemann, Pei Zhou, Edward K. Han, Alessandro Sgambato, Y. Doki, Nadir Arber, Marco Ciaparrone, Hiroki Yamamoto	104
20	Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. 1995 ·PubMed ·Edward K. Han, Alessandro Sgambato, Wei Jiang, Y J Zhang, Regina M. Santella, Yuichiro� Doki, Angela Cacace, Ira Schieren, I B Weinstein	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact